Processa Pharmaceuticals Inc. has announced that it will hold a Special Meeting of Stockholders on September 2, 2025, in Vero Beach, FL. During the meeting, stockholders will vote on a proposal to amend the company's Fourth Amended and Restated Certificate of Incorporation. This amendment seeks to increase the number of authorized shares of common stock from 100 million to 1 billion shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-011883), on August 13, 2025, and is solely responsible for the information contained therein.